| 标题 |
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Andrew S.C. Rice; Robert H. Dworkin; Tom D. McCarthy; Praveen Anand; C. Bountra; et al 出版日期:2014-02-04 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)